内容概要:肿瘤CRO服务是聚焦肿瘤药物研发的专业化外包服务,核心是凭借肿瘤领域专属技术能力和合规经验,协助药企解决研发周期长、难度高、风险大等痛点,高效推进药物从临床前到上市的全流程研发。凭藉其庞大的市场规模和显着的增长率,构成了当前CRO服务的核心领域。2024年,全球肿瘤CRO服务市场规模从2020年的72亿美元增长至162亿美元,预计2025年全球肿瘤CRO服务市场规模将达到186亿美元。...
Source Link内容概要:肿瘤CRO服务是聚焦肿瘤药物研发的专业化外包服务,核心是凭借肿瘤领域专属技术能力和合规经验,协助药企解决研发周期长、难度高、风险大等痛点,高效推进药物从临床前到上市的全流程研发。凭藉其庞大的市场规模和显着的增长率,构成了当前CRO服务的核心领域。2024年,全球肿瘤CRO服务市场规模从2020年的72亿美元增长至162亿美元,预计2025年全球肿瘤CRO服务市场规模将达到186亿美元。...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.